A Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled, Parallel Group, 3-arm Study Comparing the Efficacy, Tolerability and Safety of 2 Concentrations of NVN1000 Gel and Vehicle Gel Twice Daily in the Treatment of Acne Vulgaris.
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Novan Inc
- 29 Sep 2015 Results published in a Novan Therapeutics media release.
- 19 Mar 2014 Additional trial findings are expected in the second quarter of 2014 according to a Novan Therapeutics media release.
- 19 Mar 2014 Results have been reported in a Novan Therapeutics media release.